Literature DB >> 6174197

Diagnostic concurrence in the subclassification of adult acute leukemia using French-American-British criteria.

F R Dick, J O Armitage, C P Burns.   

Abstract

Using FAB criteria, we retrospectively classified 195 adult acute leukemia cases seen over a six-year period. Acute lymphoblastic leukemia (ALL) was separated from acute nonlymphoblastic leukemia (ANLL) by negative peroxidase. The dysmyelopoietic syndrome was separated from ANLL when the percentage of immature leukemic cells was less than 30%. The 55 cases of ALL and 140 cases of ANLL thus defined were initially independently subclassified with Wright's stained smears by three observers. Cases were then jointly reviewed by using all available information, and a final consensus diagnosis was reached. For ALL, there was complete agreement (of initial independent observations) about subtype in 32 of 55 (58%); for only one case was there total disagreement. For ANLL there was complete agreement in 89 of 140 (64%) and total disagreement in 5 of 140 (4%). Frequent disagreement of independent observations with the consensus diagnosis were L1 interpreted as 12, M5 interpreted as M4, L3 interpreted as L2, L2 interpreted as L1, M1 interpreted as M2 and M4 interpreted as M5. Although there appears to be variation between observers, all but 6 of 195 cases had at least two observers in agreement. Disagreement appeared to be partly based on varying interpretations of subjective criteria and partly on the variability in determining percentages of cell types present. The use of nonspecific esterase stain or lysozyme appeared to improve diagnostic agreement over that observed using Wright's stained slides alone in approximately 5% of cases of ANLL.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174197     DOI: 10.1002/1097-0142(19820301)49:5<916::aid-cncr2820490515>3.0.co;2-l

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  6 in total

1.  MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2.

Authors:  Shun Ke; Rui-Chao Li; Jun Lu; Fan-Kai Meng; Yi-Kuan Feng; Ming-Hao Fang
Journal:  Int J Hematol       Date:  2017-04-13       Impact factor: 2.490

2.  Reproducibility of the morphological diagnostic criteria for acute myeloid leukemia: the GIMEMA group experience.

Authors:  G L Castoldi; V Liso; S Fenu; M L Vegna; F Mandelli
Journal:  Ann Hematol       Date:  1993-04       Impact factor: 3.673

3.  Relapsing acute non-lymphatic leukemia with changing phenotypes.

Authors:  M L Mlynek; H K Mahmoud; L D Leder
Journal:  Klin Wochenschr       Date:  1985-11-04

4.  Light scatter characteristics of blast cells in acute myeloid leukaemia: association with morphology and immunophenotype.

Authors:  M B Vidriales; A Orfao; M C López-Berges; M González; A López-Macedo; M A García; J Galende; J F San Miguel
Journal:  J Clin Pathol       Date:  1995-05       Impact factor: 3.411

5.  Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2'-5'-oligoadenylate synthetase 2 axis in acute myeloid leukemia.

Authors:  Hong Zhou; Xiaofeng Jia; Fan Yang; Pengfei Shi
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

6.  Haematopoietic malignancies in Côte d'Or (France): a population based study.

Authors:  P M Carli; C Milan; A Lange; E Devilliers; H Guy; J Faivre
Journal:  Br J Cancer       Date:  1986-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.